Healthcare provider profile · identity verified

John Milan Urbancic, MD

Family Practice · CHARDON, OH · NPI 1457336562

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	744	194
Atorvastatin Calcium	Atorvastatin Calcium	688	176
Levothyroxine Sodium	Levothyroxine Sodium	598	144
Lisinopril	Lisinopril	515	115
Rosuvastatin Calcium	Rosuvastatin Calcium	428	122
Losartan Potassium	Losartan Potassium	388	109
Tamsulosin Hcl	Tamsulosin Hcl	376	60
Furosemide	Furosemide	373	95
Omeprazole	Omeprazole	373	108
Metoprolol Tartrate	Metoprolol Tartrate	334	74
Metformin Hcl	Metformin Hcl	329	75
Potassium Chloride	Potassium Chloride	291	63
Simvastatin	Simvastatin	287	71
Sertraline Hcl	Sertraline Hcl	274	64
Gabapentin	Gabapentin	273	62
Prednisone	Prednisone	269	168
Metoprolol Succinate	Metoprolol Succinate	234	71
Eliquis	Apixaban	223	49
Pantoprazole Sodium	Pantoprazole Sodium	217	59
Carvedilol	Carvedilol	211	51
Donepezil Hcl	Donepezil Hcl	203	49
Escitalopram Oxalate	Escitalopram Oxalate	197	56
Trazodone Hcl	Trazodone Hcl	180	39
Allopurinol	Allopurinol	179	44
Glipizide Er	Glipizide	159	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	156	46
Hydrochlorothiazide	Hydrochlorothiazide	155	44
Clopidogrel	Clopidogrel Bisulfate	154	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	137	39
Duloxetine Hcl	Duloxetine Hcl	120	26
Buspirone Hcl	Buspirone Hcl	119	22
Albuterol Sulfate Hfa	Albuterol Sulfate	114	45
Azithromycin	Azithromycin	112	99
Memantine Hcl	Memantine Hcl	102	17
Atenolol	Atenolol	99	22
Meloxicam	Meloxicam	92	27
Quetiapine Fumarate	Quetiapine Fumarate	85	15
Cephalexin	Cephalexin	83	66
Synthroid	Levothyroxine Sodium	80	22
Citalopram Hbr	Citalopram Hydrobromide	79	12
Mirtazapine	Mirtazapine	77	22
Spironolactone	Spironolactone	76	21
Jardiance	Empagliflozin	74	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	20
Famotidine	Famotidine	72	16
Metformin Hcl Er	Metformin Hcl	72	23
Finasteride	Finasteride	71	15
Montelukast Sodium	Montelukast Sodium	69	15
Carbidopa-Levodopa	Carbidopa/Levodopa	63	13
Lovastatin	Lovastatin	63	14
Glimepiride	Glimepiride	62	15
Pravastatin Sodium	Pravastatin Sodium	62	13
Xarelto	Rivaroxaban	61	14
Farxiga	Dapagliflozin Propanediol	60	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	19
Torsemide	Torsemide	56	14
Fluticasone Propionate	Fluticasone Propionate	55	18
Warfarin Sodium	Warfarin Sodium	54	16
Oxybutynin Chloride Er	Oxybutynin Chloride	51	suppressed
Alendronate Sodium	Alendronate Sodium	48	14
Nystatin	Nystatin	46	21
Risperidone	Risperidone	45	suppressed
Amoxicillin	Amoxicillin	44	33
Hydroxyzine Hcl	Hydroxyzine Hcl	44	16
Myrbetriq	Mirabegron	44	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	13
Bupropion Xl	Bupropion Hcl	40	14
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Mounjaro	Tirzepatide	38	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	29
Baclofen	Baclofen	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	22
Ozempic	Semaglutide	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	29
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Valacyclovir	Valacyclovir Hcl	29	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	28	27
Jantoven	Warfarin Sodium	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	20
Trulicity	Dulaglutide	28	suppressed
Digoxin	Digoxin	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Loperamide	Loperamide Hcl	26	12
Pregabalin	Pregabalin	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Ramipril	Ramipril	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Levofloxacin	Levofloxacin	21	17
Methotrexate	Methotrexate Sodium	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	15
Fluconazole	Fluconazole	19	12
Gemfibrozil	Gemfibrozil	19	suppressed
Rivastigmine	Rivastigmine Tartrate	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Hydrocortisone	Hydrocortisone	18	13
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Diazepam	Diazepam	16	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Primidone	Primidone	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	11
Metolazone	Metolazone	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Tobramycin	Tobramycin	15	13
Tramadol Hcl	Tramadol Hcl	15	suppressed
Trimethoprim	Trimethoprim	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Glipizide	Glipizide	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Risperidone Odt	Risperidone	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clozapine	Clozapine	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error